Back to REGN
DODGE & COX REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$3B
Q2 2026
Peak value
$3.5B
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $2B |
| Q2 2023 | $1.7B |
| Q3 2023 | $2B |
| Q4 2023 | $2.1B |
| Q4 2023 | $2.1B |
| Q1 2024 | $2.3B |
| Q2 2024 | $2.4B |
| Q3 2024 | $2.4B |
| Q4 2024 | $1.7B |
| Q1 2025 | $1.5B |
| Q2 2025 | $2B |
| Q3 2025 | $2.6B |
| Q4 2025 | $3.5B |
| Q1 2026 | $3.4B |
| Q2 2026 | $3B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $3B | 4.87M | — | — |
| Q1 2026 | $3.4B | 4.46M | — | — |
| Q4 2025 | $3.5B | 4.60M | — | — |
| Q3 2025 | $2.6B | 4.55M | — | — |
| Q2 2025 | $2B | 3.83M | — | — |
| Q1 2025 | $1.5B | 2.32M | — | — |
| Q4 2024 | $1.7B | 2.32M | — | — |
| Q3 2024 | $2.4B | 2.31M | — | — |
| Q2 2024 | $2.4B | 2.32M | — | — |
| Q1 2024 | $2.3B | 2.36M | — | — |
| Q4 2023 | $2.1B | 2.37M | — | — |
| Q4 2023 | $2.1B | 2.37M | — | — |
| Q3 2023 | $2B | 2.37M | — | — |
| Q2 2023 | $1.7B | 2.39M | — | — |
| Q1 2023 | $2B | 2.38M | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B
Other DODGE & COX positions
JCI
$8.1BJohnson Controls International PLC
SCHW-PJ
$7.9BThe Charles Schwab Corp.
SCHW-PJ
$7.7BThe Charles Schwab Corp.
SCHW-PJ
$7.6BThe Charles Schwab Corp.
JCI
$7.5BJohnson Controls International PLC
JCI
$7.2BJohnson Controls International PLC
SCHW-PJ
$7.1BThe Charles Schwab Corp.
JCI
$7.1BJohnson Controls International PLC